Arpad Illes

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study

2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication